SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals.

MLA

Urschel, Rebecca, et al. “SARS-CoV-2-Specific Cellular and Humoral Immunity after Bivalent BA.4/5 COVID-19-Vaccination in Previously Infected and Non-Infected Individuals.” Nature Communications, vol. 15, no. 1, Apr. 2024, p. 3077. EBSCOhost, https://doi.org/10.1038/s41467-024-47429-8.

APA

Urschel, R., Bronder, S., Klemis, V., Marx, S., Hielscher, F., Abu-Omar, A., Guckelmus, C., Schneitler, S., Baum, C., Becker, S. L., Gärtner, B. C., Sester, U., Martinez, L., Widera, M., Schmidt, T., & Sester, M. (2024). SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals. Nature Communications, 15(1), 3077. https://doi.org/10.1038/s41467-024-47429-8

Chicago

Urschel, Rebecca, Saskia Bronder, Verena Klemis, Stefanie Marx, Franziska Hielscher, Amina Abu-Omar, Candida Guckelmus, et al. 2024. “SARS-CoV-2-Specific Cellular and Humoral Immunity after Bivalent BA.4/5 COVID-19-Vaccination in Previously Infected and Non-Infected Individuals.” Nature Communications 15 (1): 3077. doi:10.1038/s41467-024-47429-8.